References
- LuCLuYChenJZhangWWuWSynchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix systemEur J Pharm Biopharm20076621021917196805
- WilliamsonEMSynergy and other interactions in phytomedicinesPhytomedicine2001840140911695885
- DeviVKJainNValliKSImportance of novel drug delivery systems in herbal medicinesPharmacogn Rev20104273122228938
- AltaeiTProtective effect of silymarin during coronary artery bypass grafting surgeryExp Clin Cardiol201217343823204899
- StickelFSchuppanDHerbal medicine in the treatment of liver diseasesDig Liver Dis20073929330417331820
- HaHLShinHJFeitelsonMAYuDYOxidative stress and antioxidants in hepatic pathogenesisWorld J Gastroenterol2010166035604321182217
- SnimaKSArunkumarPJayakumarRLakshmananVKSilymarin encapsulated poly(D,L-lactic-co-glycolic acid) nanoparticles: a prospective candidate for prostate cancer therapyJ Biomed Nanotechnol20141055957024734508
- DingTTianSZhangZDetermination of active component in silymarin by RP-LC and LC/MSJ Pharm Biomed Anal20012615516111451653
- Cordero-PérezPTorres-GonzálezLAguirre-GarzaMHepatoprotective effect of commercial herbal extracts on carbon tetrachloride-induced liver damage in Wistar ratsPharmacogn Res20135150156
- BaresJMBergerJNelsonJESilybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis CJ Clin Gastroenterol20084293794418458640
- DixitNBabootaSKohliKAhmadSAliJSilymarin: a review of pharmacological aspects and bioavailability enhancement approachesIndian J Pharmacol200739172
- HohCBoocockDMarczyloTPilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequencesClin Cancer Res2006122944295016675592
- XieYLuYQiJSynchronized and controlled release of multiple components in silymarin achieved by the osmotic release strategyInt J Pharm201344111112023253304
- State Pharmacopoeia Commission of the People’s Republic of ChinaPharmacopoeia of the People’s Republic of ChinaIBeijingChemical Industry Press, China2000
- ShahVPTsongYSathePLiuJPIn vitro dissolution profile comparison – statistics and analysis of the similarity factor, f2Pharm Res1998158898969647355
- PolliJERekhiGSAugsburgerLLShahVPMethods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tabletsJ Pharm Sci1997866907009188051
- LinJHLuAYRole of pharmacokinetics and metabolism in drug discovery and developmentPharmacol Rev1997494034499443165
- HerrlichSSpiethSMessnerSZengerleROsmotic micropumps for drug deliveryAdv Drug Deliv Rev2012641617162722370615
- SunNZhangXLuYWuWIn vitro evaluation and pharmacokinetics in dogs of solid dispersion pellets containing Silybum marianum extract prepared by fluid-bed coatingPlanta Med20087412613218240100
- Yan-yuXYun-meiSZhi-pengCQi-nengPPreparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogsInt J Pharm200631916216816687221
- KiddPHeadKA review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos)Altern Med Rev20051019320316164374
- PawarHABhangaleBDPhytosome as a novel biomedicine: a microencapsulated drug delivery systemJ Bioanal Biomed20157006012